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ABSTRACT We analyze a simple linear triggering model of the T-cell receptor (TCR) within the framework of queuing theory, in
which TCRs enter the queue upon full activation and exit by downregulation. We ﬁt our model to four experimentally characterized
threshold activation criteria and analyze their speciﬁcity and sensitivity: the initial calcium spike, cytotoxicity, immunological
synapse formation, and cytokine secretion. Speciﬁcity characteristics improve as the time window for detection increases, satu-
rating for timeperiodson the timescale of downregulation; thus, the calciumspike (30 s)has lowspeciﬁcity but a sensitivity to single-
peptide MHC ligands, while the cytokine threshold (1 h) can distinguish ligands with a 30% variation in the complex lifetime.
However, a robustnessanalysis shows that thesepropertiesaredegradedwhen thequeueparameters aresubject to variation—for
example, under stochasticity in the ligand number in the cell-cell interface and population variation in the cellular threshold. A time
integration of the queue over a period of hours is shown to be able to control parameter noise efﬁciently for realistic parameter
values when integrated over sufﬁciently long time periods (hours), the discrimination characteristics being determined by the TCR
signal cascade kinetics (a kinetic proofreading scheme). Therefore, through a combination of thresholds and signal integration, a T
cell can be responsive to low ligand density and speciﬁc to agonist quality. We suggest that multiple threshold mechanisms are
employed to establish the conditions for efﬁcient signal integration, i.e., coordinate the formation of a stable contact interface.
INTRODUCTION
Immune responses rely upon the detection of speciﬁc antigens
by T cells, antigen exposure activating a T cell which possibly
leads to cell proliferation and differentiation. The activation
process is complex and multifaceted, and despite decades of
research remains controversial. The complexity of T-cell
activation and the associated diversity of activation criterion
utilized for quantiﬁcation have made consensus illusive. Key
issues are the mechanisms that produce an activation process
that is both speciﬁc to particular antigens and sensitive down
to single copies of a ligand, and the spatial-temporal require-
ments for activation. A hierarchy of events can be distin-
guished during the process of activation. Initially the T cell
comes into surface contact with another cell where the T-cell
receptor (TCR) may interact with its ligand (peptide-MHC;
i.e., pMHC). Then TCR binding to its speciﬁc ligand leads to
phosphorylation of the receptor and recruitment of adaptors
and kinases that comprise the signaling cascade. The next
level of signaling is the integration of these signals to ulti-
mately determine cell function; this includes regulation of the
cytoskeleton, control of adhesion within the cell-cell contact
(1), directed secretion at the interface (2), and gene transcrip-
tion. Appropriate gene activation is the hallmark of cell ac-
tivation, speciﬁcally cytokine production (e.g., interleukin-2
(IL2) and interferon gamma (IFNg)), and expression of
activationmarkers such as CD69, and cytokine receptors such
as the IL2 receptor. Activation may ultimately result in cell
cycle progression through cytokine-mediated proliferation.
Thresholds have remained the predominant means of
analysis of this activation/signaling sequence, i.e., a T cell
becomes activated (as measured by function X) if the stimulus
is above a threshold. In practice, a hierarchy of thresholds
is observed for different cell responses (3–5), with good
consistency between cells for the relative threshold order:
Cytotoxicity  Cytokine production,Cell proliferation:
However, these thresholds depend on the stimulus condi-
tions, the most signiﬁcant change occurring in the presence
of co-stimulation through co-receptors such as CD28 (6). The
threshold concept received recent support from single mol-
ecule studies where thresholds in the range of 1–10 agonist
pMHCs were observed (7), signiﬁcantly lower than previ-
ously reported. However, recent experimental data suggests
that T-cell activation is not achieved in a single step or
commitment event, but is a multistep sequence of events in
which disruption of signaling proportionally reduces activa-
tion (8,9). This quantitative dependence on the temporal se-
quence of events has been observed in other studies, T-cell
survival and proliferation correlating with duration of antigen
exposure (10–12), while T cells can be activated by a series
of transient short-lived cell encounters (13). This temporal
dependence supports an earlier hypothesis that a T cell ef-
fectively counts the number of productive TCR/pMHC inter-
actions, a conclusion originally based on the high correlation
of cell response to the fraction of downregulated TCRs (14).
In this article we consider simple activation models moti-
vated by the dependence of activation on the temporal as-
pects of the signal. Our aim is to provide a framework for the
analysis of TCR triggering, incorporating, in our opinion, the
vital components of stochasticity and signal history, and
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clarifying the limitations of simple models in explaining
T-cell activation characteristics.We deﬁne threshold and signal
integration models, and analyze their speciﬁcity and sensi-
tivity. Given the complexity of the activation process our
models do not address all aspects of activation; we ignore
spatial effects, nonlinearity, and feedback. Our philosophy is
to understand the shortcomings of the simplest system to
elucidate the determinants of signal detection characteristics.
We base our models on queuing theory; a TCR enters the
queue upon full activation and exits by downregulation or
inactivation. This formulation directly accounts for the noise
associated with signaling based on a ﬁnite number of
signaling molecules. We use this model to analyze various
activation criteria reported in the literature.
Although T-cell activation has been a fertile area for
mathematical modeling there have been very few studies that
include system stochasticity (15–19), and none that have ex-
plored the consequences of low agonist density on signaling
characteristics. Conceptually, kinetic proofreading has been
a key platform on which to discuss speciﬁcity (20,21),
although this was recently criticized for being insufﬁciently
sensitive at high speciﬁcity (22). Despite these and other
T-cell activation models, theoretically it remains unclear
how complex TCR triggering dynamics must be to ﬁlter out
self-peptide noise while achieving high sensitivity, and fur-
ther, the circuit architecture that is required, e.g., strength of
nonlinear feedback (23,24), ﬁltering, or ampliﬁcation steps.
This contrasts to the Fc receptor where theoretical under-
standing is further advanced and limiting factors can be as-
sessed at the model level (25).
T-CELL SIGNALING: A SEQUENCE OF EVENTS
T-cell activation involves a complex series of spatial and
temporal events over three timescales: early (seconds); cell
and receptor reorganization (minutes); and gene activation
(hours). These are enumerated as follows:
Migration stop signal
On ﬁrst contact with an antigen-presenting cell (APC), a T
cell must be triggered to stop migrating. This stop-signal is
antigen-speciﬁc, 8% of cells stopping in absence of agonist,
95% stopping when 1–10 pMHCs were in the interface (CD4
cells with B cell lymphoma APCs (26)). This initial agonist-
dependent signal probably invokes upregulation of adhesion
receptors such as LFA-1. Dendritic cells are an exception, T
cells displaying an interest even in absence of agonist (27),
which is probably related to the antigen-independent adhe-
sion processes observed in these cells.
Calcium spikes and sustained signals
One of the earliest signals is a calcium rise, observed even
with a single pMHC in the interface (26). Calcium signals are
quantal, with the 4 min (and 10 min) integrated signal rising
linearly with pMHC over the range of 1–10 pMHCs, sat-
urating at .20 pMHCs (cytotoxic T cells (7)), .10 pMHC
(T helper cells (26)). T-cell activation has an absolute
requirement for extracellular calcium; speciﬁcally, calcium
levels must remain above 400 nM for at least 2 h during cell
stimulation for activation (28,29). However, spike dynamics
and sustained calcium levels are likely controlled by dif-
ferent mechanisms (30).
Cell polarization
Withinminutes ofAPC contact, the T cell reorients toward the
APC/target cell; speciﬁcally, actin accumulates at the inter-
face and the microtubule organizing center localizes near the
interface (31).
Synapse formation
Within theT cell-APC interface, amacroscopic patternation is
established over 3–10 min, with TCR/pMHC in the center
surrounded by adhesionmolecules ICAM-1/LFA-1 (32). This
patternation requires$10 pMHC agonists within the contact
interface (7,26). Before synapse maturation, TCR clusters are
observed at 50 s and correlate with high levels of kinase
activation (33,34), while CD8b and AKT (indicative of
phosphoinositol PIP3) aggregation occurs at the interface
within 1 min (7).
Gene transcription
The sequence of events at the molecular level is well es-
tablished for a few transcription factors; for example, NFkB
translocates to the nucleuswhen the inhibitor IkB is destroyed
onT-cell ligation (35). Elevated calcium is required to prevent
accumulation of the inhibitor and retain the transcription
factor in the nucleus (36), thereby underpinning the require-
ment for continual signaling for gene transcription.
Deconjugation
The natural termination of signaling and breakup of T cell-
APC conjugates is poorly understood. TCR triggering may
fall below the level required to sustain conjugation through
TCR downregulation or inhibition of signaling by SHP-1
recruitment (37). However, the cell environment may also
play a role, since, in three-dimensional lattices, APC inter-
actions were transient and short-lived, with an average of
6–12 min (13)—similar to the interactions observed in vivo,
indicating that a competing balance of signals may determine
T-cell dynamics (38). Despite these inconsistencies, most
reports agree that activation of naive T cells takes 10–24 h.
It is clear that there are multiple levels of information
extraction over a range of timescales in the T cell-APC
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interaction. Initial signals (e.g., indicated by cytosolic calcium
levels) must reach sufﬁcient levels to initiate formation of a
cell conjugate, with a series of later additional thresholds to
establish, for example, a synapse. There is an absolute re-
quirement for continued signaling (6); TCR triggering in the T
cell-APC interface is required to maintain the synapse since
interruption of antigen ligation results in loss of synaptic
patterning (the ICAM-1 annulus), with a decay of calcium and
kinase (PI3K) activity (9). If kinase activity is interrupted
synapse organization is also destroyed (CD2 aggregation as
the observable under PP2 treatment (8)). These studies
demonstrate that TCR triggering continues within the synapse
even though the TCR density had decreased by down-
regulation and continued signaling is essential for activation.
Of particular importance is the approximate linearity of the
T-cell response with duration of signaling; speciﬁcally,
cytokine production is linear in the total period of antigen
exposure and intermittent interruption of signaling can be
compensated by lengthening the time of exposure (8). In these
studies, signal mediators, such as calcium levels, decayed
within a minute of signaling interruption. T-cell activation is
therefore a sequence of events, earlier events such as the
calcium elevation and synapse formation probably being
required but not committing the T cell to activation or to
particular cell functions—functions that are further regulated
through a series of thresholds or checkpoints either in parallel,
or in a sequential hierarchy (3–5).
BASIC QUEUING MODEL AND THE CRITERIA
FOR ACTIVATION
In this section we present a queuing theory model for the
number of fully activated TCRs. The generation of fully acti-
vated TCRs is modeled by a kinetic proofreading (KPR)
scheme (20,21), which we discuss in the deterministic for-
mulation. A threshold strategy is deﬁned for the queuing
model as a crossing time for the (Erlang) queue, which is
solved using a Markov-chain approach. We approximate the
queue with a stochastic differential equation that provides an
analytical treatment of the stationary queue and is utilized in
the analysis of the time-integrated signal.
Initiating TCR signaling: a kinetic
proofreading scheme
We utilize a kinetic proofreading scheme (20,39), withm1 1
steps for the activation of TCRs (see Fig. 1), steps which can
correspond to TCR phosphorylation or recruitment and
activation of key kinases and adaptors (40). TCRs (denoted
by T) bind with pMHC with forward rate kon and backward
rate koff, independent of the activation state of the TCR. Fully
activated TCR/pMHC complexes are denoted as C*, and
intermediate levels of activation as Ck. Activated TCR/
pMHC complexes dissociate with rate koff into a signaling
TCR denoted by T*, which are endocytosed/downregulated
with rate m (Fig. 1). Inactivation can also be included as a
distinct process from downregulation returning TCRs to the
inactive pool, T*/ T (41); then m, now the combined rate,
is increased compared to the value used here. Down-
regulation is assumed slow, therefore a pseudo-equilibrium
is established for the complex densities (20)
C0 ¼ konTM
k1 koff
; Cr ¼ 1
11 koff
k
 r
C0 ¼ arC0; r ¼ 1; 2::m; (1)
where a[aðkkoffÞ ¼ 1=ð11 koff=kÞÞ. The pseudo-equilib-
rium approximation for C* is C ¼ ðk=koffÞCm ¼
ðk=koffÞamC0. Under changes in the KPR scheme length
m, we rescale the rate of progression k to preserve the
average time to reach the ﬁnal state, conditional on not
unbinding from the ligand, i.e., k ¼ b (m 1 1) with b ¼
(koff)opt ¼ 0.1 s1 the optimal off-rate for a TCR/pMHC
interaction.
The total number of pMHC complexes Mtotal is assumed
conserved for simplicity. This will be valid at short times and
once the synapse is formed since pMHC are trapped in the
center of the contact interface (42). There is a similar con-
servation for the number of TCRs within the pseudo-equilib-
rium approximation, which fails to hold on the downregulation
timescale under large agonist densities since ðd=dtÞðT1
+m
i¼0 Ci1C
1 TÞ ¼ mT; however, TCR numbers nor-
mally exceed the number of agonists (pMHC) by an order of
magnitude. In our applications the number of agonist pMHC
(1–1000) is low and thus the number of TCRs (10,000–
30,000) on the surface can be considered in excess. Thus,
TCR loss is negligible and the free TCR density (R) can be
approximated by the total TCR density to a good approxi-
mation.
The pseudo-equilibrium solution determines the expected
number of complex molecules in each compartment and the
intercompartment ﬂow. We deﬁne the triggering rate l as the
ﬂow of molecules into the fully activated class Cm/ C*. In
practice, the partially activated TCRs in the KPR scheme will
rapidly equilibrate and fully activated TCRs accumulate as
unbound T*; thus, at equilibrium, the triggering rate is equal
to the ﬂow C/
koff
T, giving (valid for m $ 0)
FIGURE 1 Schematic for the kinetic
proofreading scheme (KPR).
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l ¼ koffC ¼ amkC0 ¼ bðm1 1Þa
m
Mtotal
koff
akonT
1
1 am1 1
1 a 1
bðm1 1Þam
koff
:
(2)
Note that if koff/ N, the triggering rate decays to zero as
bð11mÞkonTMtotalkm11k2moff .
Modeling triggered TCRs as a queue
Each compartment Ck in the KPR scheme can be considered
as a queue. These are Poisson queues with Poisson input, and
thus the output process Ck to Ck11 is also Poisson (total exit
rate is (kon 1 koff)E[Ck] at stationarity and a probability a of
progression). Thus, the free TCR queue T* is therefore a
Poisson queue,
!l¼koff C !mTðtÞ downregulation;
or a jump Markov process comprising two independent
Poisson processes with rates l ¼ koffE½C* and mT*(t) and
jumps of size 11 and –1, respectively.
We deﬁne a threshold condition for cell activation with
signaling threshold n as the requirement that the number of
fully activated TCRs must exceed n within a (given) time
interval t, i.e., T*(t) . n at some time t , t. In terms of the
queue, the probability of activation is
P ½TðtÞ, n for t, t9,Tðt9Þ ¼ njTð0Þ ¼ 0, 0, t9, t:
(3)
This probability is the ﬁrst crossing probability for level
n where crossing is required to occur within time t. First
crossing times can be analyzed with Markov chains and
approximated using large deviation theory.
To simplify our analysis, we restrict ourselves to enumer-
ating only the free fully activated TCRs (i.e., we ignore the
contribution from the C* compartments, which are also fully
competent at signaling since m  koff and thus C*(t) is a
minor population, CðtÞ  TðtÞ). We also assume that TCRs
are in excess and thus the pool-size of free TCRs is constant
(even though TCRs are held within compartments Ck and
C*, and are downregulated). These assumptions can be
dropped, but complicate the exact analysis. Note that our
queue counts an absolute number of activated TCRs T*,
which contrasts to the free TCR pool-size enumerated as a
density R.
Exact Markov-chain computation for
threshold strategies
We are interested in estimating the probability of reaching
the threshold n starting from an initial level of 0 (Eq. 3).
Since the process T*(t) is a continuous-time Markov process,
with T*(0) ¼ 0, and T*(t) ¼ n for some t # t, we construct
the Markov chain with states k ¼ 0, 1, . . ., n–1, n and deﬁne
the probabilities pk(t) of occupancy of state k at time t.
Denote by p(t) ¼ (p0(t), p1(t), . . ., pn(t)), the probability
vector of state occupancy at time t, then the transition
dynamics is given by dp/dt ¼ pG, where the generator
matrix G is given by
Note that the ﬁnal state is now a sink, since we are computing
a crossing time. In the threshold strategy, we are interested in
calculating P[T*(t)$ n for any t# t]. At time t¼ 0 we have
p(0) ¼ (1, 0, . . ., 0) and at time t . 0,
pðtÞ ¼ pð0ÞeGt: (5)
The desired probability Pact(t, l, n) ¼ P[T*(t) $ n at some
t , t] ¼ pn(t). This is a function of the time-interval t and
the triggering-rate l (Eq. 2), which is itself a function of
agonist densityMtotal and agonist quality, predominantly koff.
In fact we determine the threshold n in Results by ﬁtting
the probability Pact to a number of speciﬁc experimentally
observed values described in Table 1.
A stochastic differential equation model
The queue model can be approximated by a stochastic
differential equation (sDE), an approximation that improves
as the equilibrium queue size increases. Let T*(t) 2 R be the
number of triggered TCRs in the queue, now a continuous
random variable, then the dynamics is given by dT ¼
l mTð Þdt1sðTÞdW, where W(t) is a Weiner noise and
s(T*) is the standard deviation of the process. To ﬁt param-
eters we match the variance with that of the queue. For a
time-interval Dt, varqueue(DT*)¼ var(input)1 var(output)¼
G ¼
l l 0    0
m ðl1mÞ l 0    0
0 2m ðl1 2mÞ l 0    0
..
.
0    0 km ðl1 kmÞ l 0    0
..
.
0    0 0 0
0
BBBBBBBBBB@
1
CCCCCCCCCCA
: (4)
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lDt 1 mT*Dt; thus equating this to the variance of the sDE,
we obtain s2 ¼ l 1 mT*(t).
The expected queue size E½T* satisﬁes the differential
equation d E½T*=dt ¼ l mE½T*; i.e., there is an expo-
nential approach to the stationary (equilibrium) level r ¼ l/m.
Our interest is in ﬂuctuations around the stationary equilib-
rium, so we simplify the sDE. Deﬁne X(t) ¼ T*–r, then
dX ¼ mXðtÞdt1sdWðtÞ,s ¼ ð2lÞ12, (6)
where we ignore dependence of the noise s on the state,
valid if ﬂuctuations X(t) are small relative to r. This is, in
fact, the Ornstein-Uhlenbeck process for which the exact
solution is given by
XðtÞ ¼ Xðt0Þ exp½mðt  t0Þ
1 ð2lÞ12
Z t
t0
exp½mðt  sÞdWðsÞ, (7)
i.e., X(t) is a sum of Gaussians (X(t0) ﬁxed or drawn from a
Gaussian), and therefore X(t) is normally distributed with
mean and variance,
E½XðtÞ ¼ exp½mðt  t0ÞE½X0;
var½XðtÞ ¼ exp½2mðt  t0Þ varðX0Þ  s
2
2m
 
1
s
2
2m
:
In particular, when X(t) is stationary, i.e., when t0/N, we
ﬁnd E½X/0 and varðXÞ/s2=2m.
Time-integrated signals: quantifying responses
in the stationary queue
To quantify T-cell responses under an integrated signal,
deﬁne the functional
aðtÞ ¼
Z t
0
T*ðtÞdt (8)
as a measure of the signal strength over the duration of time
t. For example, a triggered TCR T* acts as a source of
activated signaling mediators throughout its lifetime. This
measure of signal strength will be appropriate provided there
are no limiting factors down-stream. More generally we
could use aˆðtÞ ¼ R t
0
ðTðtÞ=ðK1TðtÞÞdt if there is a limiting
factor with a saturation level K, e.g., Lck limitation (43).
Most of our analysis is with low levels of agonist, and thus
we assume saturation does not occur.
We wish to compute E½aðtÞ and var[a(t)] for the system
while at stationarity. For the Ornstein-Uhlenbeck process,
a(t) is Gaussian with
E½aðtÞ ¼ rt ¼ l
m
t;
var½aðtÞ ¼ 2
ZZ t
s. u
E½XðsÞXðuÞdsdu
¼ s
2
m
3ðmt1 exp½mt  1Þ: (9)
For large t we have var[a(t)] s2t/m2 2lt/m2. This gives
an estimate for the relative error as
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2=lt
p
; in particular, the
error is reduced for a given triggering rate by extending the
time interval. For triggering rates of 0.4 per second, e.g., an
optimal agonist at densityMtotal 10 in the contact interface,
a relative error of 2% is achieved over a time interval of 5 h.
Incorporating TCR downregulation
Over extended periods at high agonist density, TCR down-
regulation can have a signiﬁcant impact on signal strength and
thus needs to be incorporated in signal-integrationmodels. To
model TCR downregulation kinetics, letW be the production
rate of TCRs to the cell surface per second, m0 be the
constitutive rate of loss of TCRs from the cell surface per
second, and md be the rate of triggered TCR endocytosis
TABLE 1 Parameter values used to match experimentally observed activation probabilities with optimal agonists, dissociation
rate koff ¼ 0.1 s1, and with m ¼ 7 activation reactions (see Basic queing model and the criteria for activation)
Label Time t M (# pMHC) Threshold* Pact at koff ¼ 0.1 s1y Equilibrium Remarks
Ca 30 s 2 1 0.86 (0.95) 22 (26)
Calcium signals sustained on 2 pMHC, 95% of cells stop migrating. Calcium peaks at 30–60 s.
Cx 10 min 3 25 0.8 (5/6) 33 (7)
Cytotoxicity (2C cells) observed after 5–15 min: 1/9 cases at 2 pMHC, 5/6 cases at 3 pMHC.
IS 30 s 10 6 0.91 (0.90) 108 (7,34)
Synapse formation with 10 pMHC in ;90% of cases, early TCR clusters seen by 50 s.
Cy 3 h 100 1172 0.50 (0.50) 1082 (52)
IFNg secretion, 100 nM pulsing (;100 pMHC) gives 50% of maximum signal.
B 10 min 10 83 0.9 108 IS comparison
C 1 h 10 121 0.9 108 IS comparison
D 10 min 100 908 0.5 1082 Cy comparison
E 1 h 100 1147 0.5 1082 Cy comparison
*Computed from Eq. 5 to the nearest integer.
yValue in parentheses is estimated from the cited study.
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(triggered TCRs being destroyed (44)). Thus, we are not
explicitly modeling TCR recycling (45). We have dynamics
dR
dt
¼ W  md
T*
A
 m0R; (10)
where we introduced the area of the cell A; 300 mm2, since
R is a density while the queue is an absolute count of triggered
TCRs. When there is no ligand, i.e., T*¼ 0, we have a steady
state given by Rss,0 ¼ W/m0. When agonist is present, the
surface TCR density decreases with an equilibrium given by
the quadraticW–l(koff,R,M)A
1 –m0R¼ 0, settingmdT*¼l.
The new steady state is, using the triggering-rate expression
Eq. 2,
R ¼ 1
2m0c
½a1 cW  bm01 fðcW1 bm0Þ2
 2aðcW  bm0Þ1 a2g1=2, (11)
where a¼ amkMtotal/A, b¼ (k1 koff)/kon, and c¼ (1 am)/
(1 – a) 1 kam/koff. Steady-state TCR densities are shown in
Fig. 2 under differing levels of agonist density and quality
(koff); in particular, at low levels of agonist (Mtot , 1000),
downregulation can be ignored. The positive root is the only
physical solution. Linearization in Mtotal gives R ; Rss,0 –
aW/(m0(cW 1 m0b)).
More complex models for downregulation have been
presented elsewhere (41,46).
RESULTS
Fitting activation strategies
To assess the relative merits of thresholds set over different
periods of the activation process, we deﬁne a number of
activation strategies based on experimentally determined con-
ditions. These encompass both early and late decisions. A
threshold strategy for a particular cell response consists of a
commitment timescale t for the cell response and the prob-
ability of activation of that response at a given agonist
concentration within that time t. Speciﬁc strategies, with
identifying labels used throughout this article, are as follows
(see Table 1):
Ca. . .Calcium threshold with a time window t ¼ 30 s. This
is the initial interest signal to strengthen the contact, the
cell moving on without this signal.
Cx. . .Cytotoxic response, i.e., cell-killing (CD8 T cells),
which occurs on a timescale of 5–15 min with high
sensitivity.
IS. . .Immunological synapse formation, or the formation of
a macroscopic receptor patterning in the T cell-APC
contact interface, initial reorganization being visible by
50 s of contact.
Cy. . .Cytokine secretion, requiring gene transcription, and
which occurs on a scale of hours.
For example, during the initial contact of a T cell with an
APC, there is a competition between continuation of peptide-
scanning on the cell surface and signals to move-on. The
latter signals possibly derive from the extracellular matrix
since artiﬁcial three-dimensional matrix studies observed
short scanning times of mean duration 6–12 min, indepen-
dent of agonist (13). Thus, if sufﬁcient stimulus is received
from the APC, the cell will strengthen its adhesive contact
and enlarge the area of contact, e.g., through LFA-1 afﬁnity
upregulation (47), and orient toward the APC. This initial
interest signal we encompass in the calcium threshold con-
dition Ca (see Table 1), simplifying the analysis to a set time-
interval t instead of the competition of signals implied
above, where t would be exponentially distributed. Because
these strategies vary in the cell threshold n, activation prob-
ability Pact, and time-interval t, we supplement these with
additional sets, B–E (see Table 1), to provide a basis to assess
the effect of the various parameter changes.
Mathematical ﬁtting of an activation strategy requires us to
determine the activated TCR threshold n given the activation
probability Pact under the speciﬁed conditions, i.e., using
Eq. 5. In general, this threshold is low for short time-windows
and low agonist-density Mtotal, and increases as t or M are
increased; i.e., we need more activated TCRs to match the
given activation probability (Table 1). Further, the threshold n
is not necessarily less than the queue equilibrium level r.
Activation probabilities
Kinetic proofreading scheme length
To determine an appropriate length for the kinetic proofread-
ing scheme (see Fig. 1), we examined the triggering rate as a
function of off-rate koff with different numbers of intermediate
steps m, rescaling the transition rate k } m 1 1 to preserve
sensitivity. This differs from the study of Chan et al. (22), who
analyzed an unconstrained system—thus explaining our
differing conclusions. Although the triggering rate was
FIGURE 2 Equilibrium TCR surface density (mol mm2) as a function of
agonist numbers M in the interface. Cases shown are koff ¼ 0.01, 0.1, 0.4,
0.7, and 1.0 s1, with less downregulation as koff deviates further from the
optimal off-rate 0.1 s1.
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maximal at ;koff ¼ 0.1–0.2 s1 for all m, the triggering rate
becomes more concentrated around the optimum as m
increases (Fig. 3 A). When there are no intermediate steps,
the triggering rate had a weak dependence on koff, and above
m¼ 3 there is little dependence onm. Because of the rescaling
of the transition rate k with m, the sensitivity and speciﬁcity
converge asm/N; the probability of an agonist to become
fully activated converges to ekoff=b, or;0.37 for an optimal
agonist. The speciﬁcity can be quantiﬁed in terms of
the elasticity ð@logPactÞ=ð@log koffÞ ¼ ðkoff=bÞ (evaluated
for m / N), indicating a log-per-log relative change in
the speciﬁcity for an optimal agonist, i.e., DPact/Pact 
Dkoff/koff. We use m ¼ 7 in the following, although all
m. 3 had similar behavior (data not shown). The triggering
rate increases in Mtotal (in fact, linearly) as indicated by
Eq. 2. This highlights the interplay between agonist quality
and agonist density in all kinetic proofreading schemes;
poor agonist quality can be compensated for by a higher
density of agonist, i.e., there is a continuum of {Mtotal, koff}
giving the same triggering rate (Fig. 3 C) and thus activation
characteristics.
Queue dynamics
We initiate the queue at t¼ 0 (ﬁrst contact) with T*¼ 0. The
queue then ﬁlls with approximately linear kinetics before
settling at an equilibrium level (Fig. 4). Since the down-
regulation rate is slow, a fully activated TCR has an average
lifetime of 5 min (m1), and thus contributes to signaling for
that period of time. This timescale determines the approach
to equilibrium, E½TðtÞ ¼ lð1 emtÞ=m, i.e., at 10 min, it
is within 17% of the equilibrium value (Fig. 4). This means
that for time intervals t ,;5 min, the queue size is
effectively the count of the number of triggering events. This
is what distinguishes the behavior between time intervals of
30 s and 5 min with $10 min; once the queue has reached
equilibrium the queue no longer counts productive trigger-
ings. Thus, we expect large behavioral differences between
30-s and 10-min time intervals, but much less between 10min,
1 h, and 10 h because, in the latter, the queue is effectively
stationary. This is clear from the differences between the
threshold and equilibrium values for the various conditions
(see Table 1); at short times the thresholds are very low,
much lower than the steady-state queue size. This is because
the threshold is implemented on the rising phase of the
queue.
Speciﬁcity at given agonist density M
Of key importance to T-cell activation is the sensitivity of
the system to small numbers of agonist peptides and the
speciﬁcity of the system to ligand quality; for T cells, the
primary determinant of activation, or measure of ligand
quality, is the TCR/pMHC off-rate, koff (48).
The ability to discriminate agonist quality (koff) varies
signiﬁcantly between the activation strategies of Table 1; the
FIGURE 3 Triggering rate l depen-
dence on agonist density M and KPR
scheme length m. (A) Variation in trig-
gering rate l with koff for various KPR
sequence lengths m and M ¼ 10 peptide-
MHC complexes. (B) Variation in trig-
gering rate l with koff for various M and
length m ¼ 7 ﬁxed. (C) Triggering-rate
contours l ¼ 1, 2, 3, 5, and 10 s1 in the
koff –M plane, showing interdependence
between these two parameters.
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threshold strategies based on low agonist numbers (Mtotal #
10) are poor at discriminating peptides (Fig. 5) compared to
those at higher densities. The primary factor governing
speciﬁcity is the queue occupancy size, or threshold level,
with order Ca , IS , Cx , Cy identical to the speciﬁcity
order. Factors that increase the threshold improve speciﬁcity
since the noise is reduced; thus strategies using either higher
agonist densities Mtotal or longer time intervals (allowing
activated TCRs to accumulate in the queue) have higher spec-
iﬁcity. However, because of loss processes from the queue,
there is little further improvement after time intervals that
exceed 10 min; this is illustrated in Fig. 5 for cytokine se-
cretion (t ¼ 10 min and t ¼ 3 h are practically indistin-
guishable) and Fig. 6 for IS strategy. The limiting factor in
speciﬁcity improvement is the downregulation rate. Im-
provements with duration t arise because the queue size
increases, but this saturates as the queue reaches equilibrium,
while the expected queue size l/m is limited by the down-
regulation rate m for any given triggering rate. The optimal
strategy is to count the number of triggerings (17), which is
effectively achieved by the queue up to t , m1. Thus, for
t $ 10 min, a T cell has a tight speciﬁcity in koff at low
agonist numbers (M ¼ 10), which contrasts to the broad
response seen at t ¼ 30 s (Fig. 6 A). To sharpen the response
further, the downregulation rate would have to be reduced
with a time t ; m1 achieving near-optimal speciﬁcity.
The speciﬁcity is in fact higher than can be achieved for
the deterministic KPR scheme of Fig. 1. This is because of
the use of a threshold. If there was no noise, the range of koff
values that trigger a T cell at a given density of agonist would
be given by l(M, koff) . nm (using steady state for il-
lustration, i.e., a long time-interval t). This range can be
obtained from the contour plot in Fig. 3 C by locating the
interval in koff between the intersections of the contour and
the vertical corresponding to the appropriate Mtotal density.
As M increases, the range extends; i.e., poorer agonists can
activate the T cell. With noise, these qualities are preserved
except that the sharp boundary is smoothed. The extended
range in koff with higher Mtotal means that speciﬁcity is
very sensitive to agonist density (Fig. 5 C). The KPR
scheme determines speciﬁcity degradation with increasingM
since the boundaries move as ðdkoff=dMÞjl¼nm1 along the
triggering-rate contour l.
The kinetic proofreading scheme is essential for high spec-
iﬁcity, because triggering-cascades with zero intermediary
steps (m ¼ 0) have an extremely poor speciﬁcity (Fig. 6 B),
the activation probability for very weak agonists (koff ;
1 s1) becoming substantial at t ¼ 30 s. Extending the time
FIGURE 4 Queue trajectories. Three sample paths for the process T*(t)
and the expected trajectory (shaded line) forM ¼ 10 and koff ¼ 0.1 s1. The
equilibrium value r of the number of a triggered TCRs is 108. Paths
simulated with a Monte Carlo scheme.
FIGURE 5 Speciﬁcity. The response
peaks around the optimal koff with
varying abilities to ﬁlter-out nonspeciﬁc
agonists. (A) Comparison of T-cell acti-
vation under threshold conditions of
Table 1. Cases are: Calcium (solid), t ¼
30 s, Pact ¼ 0:95, n ¼ 1, M ¼ 2;
Synapse formation (dash), t ¼ 30 s,
Pact ¼ 0:9, n ¼ 7, M ¼ 10; Cytotoxicity
(dot-dash), t ¼ 10 min, Pact ¼ 5=6, n¼
25, M ¼ 3; and Cytokine secretion
(dotted), two cases at 10 min and 3 h,
Pact ¼ 0:5,M¼ 100. (B) As panel A but
with log-scale. (C) Cytotoxicity signal at
10 min showing loss of speciﬁcity as M
increases.M¼ 3 (solid) andM¼ 10, 20,
30 (dot-dashed, dotted, dashed). In all
cases, m ¼ 7 for the KPR scheme.
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interval to t ¼ 10 min improves the speciﬁcity, but it remains
an order-of-magnitude broader than them¼ 7 KPR sequence.
Sensitivity and background stimulation
Sensitivity of T-cell activation to agonist density is shown in
Fig. 7, demonstrating an effectively switchlike behavior for
activationwith respect to pMHC densityM. This behavior is a
consequence of the threshold criterion and the linearity of the
triggering rate on pMHC density Mtotal. Since poor agonist
quality can be compensated by high agonist density to give the
same triggering rate (Fig. 3 C), it is not surprising that T cells
can be activated under a threshold strategy by poor agonists at
sufﬁciently high density; in fact, there is a reasonably modest
increase in agonist density from 100 to 150 under a reduc-
tion in mean complex lifetime from 10 s to 3 s ($10 min
threshold), while a lifetime of 1 s requires M . 6400. This
emphasizes the combined effects of half-life and agonist
density on speciﬁcity; for the cytokine strategy at agonist
densities in the range of 100,M, 125, we can discriminate
koff¼ 0.1 and 0.2 s1, while forM, 100 there is no response
to either agonist, and for M . 130 these agonists cannot
be distinguished (Fig. 7). Strategies with higher thresholds
perform better at discriminating between good and poor
agonists in that a greater absolute increase in pMHCnumber is
required.
We observe that for neutral agonists with koff ¼ 3 s1
(lifetime 0.3 s), pMHC numbers of the order of 105 are
required to achieve a triggering rate sufﬁcient for activation
(cytokine strategy), while 1000 peptides with koff ; 1 s
1
have a negligible triggering rate. This indicates that back-
ground activation can effectively be ﬁltered out provided that
self-peptide half-lives are sufﬁciently small.
Variable agonist density
Only with recent individual pMHC ﬂuorescence studies has
the number of pMHC within the contact interface been ob-
served (7). In practice, the number of agonists in the interface
is stochastic for a given level of infection, or peptide pulsing.
Further, the area of the T cell-APC contact interface does not
cover the whole APC surface. We model the number of
agonists M as Poisson with mean (and variance) denoted
M. This is appropriate if the area of the contact interface is a
ﬁxed proportion of the APC surface, e.g., as may be appro-
priate in a mature synapse, since the number of pMHC
agonists in the interface does not appear to change over time
(7). To analyze how the activation probability varies with M,
we compute
EM½PactðMÞ ¼ +
M
PactðMÞexpf Mg
M
M
M!
; (12)
i.e., we weight the activation probability over the distribution
in M. Here, PactðMÞ ¼ Pðt,lðkoff ,MÞ, nÞ.
Under this stochastic model, the switchlike behavior
observed under variation of M is degraded, Poisson noise in
M dominating the intrinsic variation in the queue (Fig. 8).
The cytokine response in the case t ¼ 10 min and t ¼ 1 h are
FIGURE 6 Comparison of the immu-
nological synapse (IS) threshold strategy
for ﬁxed agonist density M ¼ 10 at
various time points t ¼ 30s (solid), 10
min (dash), and 1 h (dot-dash). To
compare the response, we set
Pact  0:9 for each time period under
optimal dissociation rate conditions,
koffð Þopt¼ 0:1 s1. (A) KPR sequence
lengthm¼ 7. For t¼ 30 s, the threshold
is n ¼ 7. When t ¼ 10 min, t ¼ 1 h the
threshold is raised to n¼72 andn¼ 108,
respectively. (B) The casem¼ 0, i.e., no
intermediate activations, showing re-
duced speciﬁcitywith respect to panelA.
FIGURE 7 Sensitivity. Activation probability Pact as a function of the
agonist densityM, calcium (Ca), and cytokine secretion (Cy) strategies. A T
cell shows a sharp, switchlike behavior in agonist density M, rising sharply
over a very narrow range of M. Left set of curves correspond to the calcium
threshold, t¼ 30 s, right set to the cytokine secretion threshold at t¼ 10 min
(thin) and t¼ 1 h (thick line). The leftmost curve of each group corresponds to
koff ¼ 0.1 s1 (solid), the middle to 0.2 s1 (dash) and the rightmost one to
0.03 s1 (dot-dash). For the calcium response, the case koff ¼ 1 s1 is also
shown (dotted); for the cytokine strategy, this is positioned at;M¼6400. For
each threshold, the optimal agonist with koff ¼ 0.1 s1 requires the minimal
number of agonists to activate.
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almost the same in the presence of noise with a broad
response ranging from 75 to 125 in (mean) agonist density
in contrast to the range of 90–105 in the nonrandom case
(koff ¼ 0.1 s1). Thus, 0.1 s1 and 0.2 s1 are no longer
distinguished. This clearly demonstrates that for threshold
models the number of triggered TCRs is a good indicator of
the actual triggering rate in the interface, i.e., it is both
speciﬁc and sensitive. However, variation in the number of
agonists, and thus the triggering rate, causes a loss of speci-
ﬁcity and sensitivity. Achieving control and accurate sam-
pling of the APC surface therefore appears to be a more
signiﬁcant problem than the stochasticity inherent in the
queue itself, possibly providing an explanation for the role of
the immunological synapse.
Variance in the threshold and time window
The considerations above apply to all the parameters of
the system, since they are themselves subject to stochastic
ﬂuctuations. For each of the parameters, we can deﬁne a
tolerance width for the activation probability (for a given
peptide lifetime and density) as the length of the parameter
range over which the probability Pact rises. As with any
probability distribution, the width is quantiﬁed by the vari-
ance; thus, the total variance is then given to leading order by
(assuming parameter variations are independent)
varðPactÞ ¼varðPactÞj M;t::1 varðMÞ
@Pact
@M
j M;t::
 2
1 varðtÞ @Pact
@t
j M;t...
 2
1 . . . : (13)
Thus, for any parameter, the smaller the relative tolerance ¼
tolerance/mean, the more sensitive the system is to that
parameter. Speciﬁcally, if a parameter has a relative error
smaller than the relative tolerance-width of the process,
its stochasticity is irrelevant, otherwise its stochasticity
degrades the detection characteristics of the queue. For
agonist density, the relative tolerance of the cytokine strategy
was ;1%, and thus the system was very sensitive to
variation in agonist numbers (Fig. 8). Tolerance to queue
parameters, however, appears more robust with relative
tolerances .5% (cytokine threshold) for optimal agonists,
while the calcium and synapse strategies were very sensitive
to the threshold n and period t (Fig. 9). There remains strong
dependence on t even at 10 min (Fig. 9 C), where t must be
in the range 550–650. Under signal competition, e.g.,
between remaining with the APC versus moving on, an
exponential distribution for t seems justiﬁable with relative
error ¼ 1. Of note, however, is that a hierarchy of thresholds
and events reduces this relative error and thus later events
such as cytokine secretion may be less constrained by these
problems. For variation in the threshold n, the dependence is
also strong; for koff ¼ 0.1 s1, the dependence resembles a
Poisson distribution (var  mean). Thus for the synapse
threshold, n has a range 7–13 for 0:1#Pact# 0:9, with 50%
point at 10, while for the cytokine threshold at 10 min, the
corresponding range is of size 30, 50% point at 908. Thus, if
there is variation in n that exceeds this range, then Pact as a
function of koff and M acquires additional variance—i.e., the
dependence on these variables is broader than the queue at
ﬁxed t and n would indicate.
Temporal integration of signals
To analyze time-integrated signals, we integrate over the
queue T* for a period of time t (hours). We assume the
queue is in stationary equilibrium—a good approximation,
since the queue equilibrates in time m1. If downregulation is
included, we integrate over the queue once the T-cell pool
size has equilibrated (equilibrium density levels are shown in
Fig. 2). This is justiﬁed, because the initial transient is short
relative to the timescales of integration, and there is often a
minimum time of interaction (dead-time) before any cell
function is observed.
The integrated signal aðtÞ ¼ R t
0
Tdt is monotonically
increasing in agonist number M and time t, although with
downregulation it saturates in the former at highM (Fig. 10A)
but remains linear in t. It has a maximum in the off-rate close
to koff ¼ 0.1 s1 (Fig. 10 B), a property determined by the
underlying kinetic proofreading scheme, since E½aðtÞ ¼
lðM, koffÞt=m. However, as l saturates at high agonist con-
centrations, it loses dependence on koff and thus, speciﬁcity is
degraded. This saturation differs from the threshold model,
where saturation was implicit in the threshold mechanism and
restricted speciﬁcity to a small range of agonist concentra-
tions. The integrated signal also differs substantially from the
threshold model in that it is quantitative, and thus there is the
additional complication of the variance in the signal. How-
ever, this variance is small for time integrations of the order of
an hour (Fig. 10 B).
FIGURE 8 Sensitivity with noise. The expected activation probability
with agonist density M, IS, and Cy strategies. The responses when there is
no noise in the agonist density are shown in gray (Cy as in Fig. 7) and under
a Poisson distribution for pMHC density in black (against mean pMHC
density). The cases shown are t ¼ 30 s (IS strategy) on far left, t ¼ 10 min
(thin line) and t ¼ 1 h (thick line) for the Cy strategy on right with cases
koff ¼ 0.1, 0.2, and 0.03 s1 (solid, dashed, dash-dot) as Fig. 7.
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Parameter variation in the queue degraded the speciﬁcity
of the threshold criteria. However, for the time-integrated
signal, the variance associated with triggering and down-
regulation can be controlled since it contributes to the vari-
ance s2 (Eq. 9), an argument that is valid provided the time
interval of integration is longer than the timescale of any var-
iation in these parameters. Such noise can thus be ﬁltered out
by using longer time intervals t. Cell-to-cell variation, i.e., var-
iation in queue parameters, still remains a problem. Of course,
short sampling time intervals t will have poor speciﬁcity; for
the queue alone, the relative error is 10%, with time intervals
of the order of 10 min (at triggering rates of 0.4 s1).
CONCLUSION
We analyzed two types of activation processes in the context
of a simple linear queue of TCR triggering, speciﬁcally
threshold models where the number of fully activated TCRs
must exceed a threshold n (within a time window t), and
integration of signals from a population of triggered TCRs
for a period t. Our study has shown that both systems can be
highly speciﬁc and sensitive, and able to ﬁlter out back-
ground (self-peptide) noise, i.e., can meet both the compet-
ing demands of detection of low levels of agonist and
discriminate between ligands varying by as little as 30% in
their off-rates (49). In fact, threshold models are able to im-
prove on the speciﬁcity of the KPR sequence within narrow
agonist concentration ranges, but lose speciﬁcity as the ago-
nist concentration increases. In contrast, time-integrated sig-
nals over the stationary state have a speciﬁcity determined by
the underlying KPR kinetics, and lose speciﬁcity only at very
high agonist concentrations through saturation of the trig-
gering rate by processes such as downregulation. For both,
speciﬁcity improved with the length of the KPR scheme,
although under the constraint that sensitivity was preserved
(implemented by rescaling k) the effect was large for changes
FIGURE 9 Dependence of the thresh-
old model on time interval t (seconds).
(A) Calcium (Ca) signal; (B) immuno-
logical synapse (IS) signal; (C) cytokine
secretion (Cy) signal at t ¼ 10 min.
Various koff values are shown: koff ¼
0.03 (dot-dash), 0.1 (solid), 0.4 (dashed),
0.6 (dotted), and 1.0 (ﬁne dotted) s1.
Some curves are close to the axis; for
panel C, only koff ¼ 0.1 s1 is visible.
FIGURE 10 Time-integrated signal E½aðtÞ. (A) E½aðtÞ as a function of agonist numberM for various koff: 0.1 (solid), 0.6 (dot-dash), 1.4 (dashed), and 0.01
(dotted) s1, with t ¼ 1 h. (B) E½aðtÞ as a function of koff; variousM¼ 10, 20, 100, and 200 with associated standard deviation (error bars) for an integration
time window t ¼ 1 h. Units of E½aðtÞ are molecule days.
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m ¼ 0 through to m ¼ 3, and thereafter improvement was
small. Other models for TCR activation can also be used; for
instance, the heterodimer model of activation (50), the trig-
gering rate l-dependence onM and koff of these models then
determining the speciﬁcity of the queue and signal-integra-
tion models.
System tuning was found to be a signiﬁcant problem for
threshold models, the system parameters need to be tightly
controlled for high speciﬁcity. In practice, there is likely to
be intrinsic variability in the downregulation rate, the thresh-
old level, the time window t, and KPR kinetics both within a
cell (spatial and temporal heterogeneity) and across a clonal
population of T cells. Time-integrated signals can control the
signal variance by extending the length of the time-integra-
tion interval and thus are better estimators of the triggering
rate. These results can be understood from consideration of
the number of events sampled; time integration increases the
number of triggering events sampled as serial triggering of
TCRs by peptide-MHC agonists continually report on the
presence of the agonist. As the sample size N increases, the
relative error of any estimate decreases as 1=N1=2. Signal
integration over the stationary distribution gives a quantita-
tive signal which, once noise levels are low, has a speciﬁcity
determined by the KPR kinetics and thus the analysis is
identical to that of the ordinary differential equation for-
mulation (20,21).
Our study has emphasized a key difference between
thresholds set on early and late signals. The speciﬁcity im-
proved as the time-interval t approached t  m1; however,
further increase in t gave little improvement. This is because,
for t , m1, the queue is counting productive triggerings—
which is, in fact, an optimal strategy (17). Thresholds set on
the rising transient of the signal are thus optimal for that time
period, while those at times greater than the half-life of a
triggered TCR (m1) are monitoring the stationary distribu-
tion of the activated TCR population. We also found that of
the strategies examined, speciﬁcity and sensitivity were
inversely correlated; thus strategies with short time intervals
and low thresholds were highly sensitive, but had marginal
speciﬁcity, while strategies on long time intervals and high
thresholds were highly speciﬁc, but utilized higher levels of
agonist. Fundamentally, this implies that in any discussion of
speciﬁcity the function and conditions must be deﬁned since
it is consistent to have both high sensitivity and speciﬁcity,
as observed for the early calcium signal and late cytokine
secretion signal respectively. We predict that, as speciﬁcity
and sensitivity are further examined for each cell function,
this inverse correlation will be realized. In our model we
assumed that activated TCRs are downregulated; however,
inactivation (dephosphorylation) has also been suggested to
occur (41). In the queue model this would increase the rate m
of activated TCRs leaving the queue. This would alter our
conclusions in the following respects: the queue would have
a lower occupancy and thus high intrinsic noise, and reach
steady state faster. Thus, the optimum time for the threshold
would decrease below 5 min, while all strategies after that
time would have reduced speciﬁcity.
T-cell activation is probably a mix of threshold and time-
integration signals; for example, a small transient calcium
spike is sufﬁcient to activate the transcription factor NFkB
but insufﬁcient for NFAT (51). Threshold models have the
advantage of speed and thus can be used to prevent extended
unproductive APC contacts and quickly locate productive
contacts, while their speciﬁcity properties are easily satu-
rated with increasing agonist. This suggests that thresholds
are predominantly used to establish conditions for efﬁcient
signal integration and to determine when signal integration
occurs. Cell spreading, adhesion upregulation, cell reorien-
tation, and possibly synapse formation are thus early pre-
requisite events for the formation of a stable surface contact
with the APC, which we hypothesize are controlled by thresh-
olds. Adaptation of these thresholds to the current conditions
also allows T cells to reorient toward higher stimulus APCs
(31,52), while transient interactions (13) could be controlled
by threshold events to optimize high-quality interactions and
orchestrate signal integration over a series of contacts—a
series of sequential APC conjugations that could partially
accommodate for variation between APCs. Signal integra-
tion on the scale of hours is more robust to system noise and
retains speciﬁcity over a range of agonist concentrations.
However, signal integration also allows for quantitative
responses, relative degrees of activation being observed in T
cells, which underpins competition and selection (53–57).
The mechanism for this selection is probably the quantitative
correlation of stimulus with receptors such as the IL2
receptor (12,29). This contrasts to the innate immune system
where maturation and selection do not occur; NK cells, for
instance, have been proposed to be regulated by a series of
checkpoints (31). We have also commented that high levels
of weak agonists and low levels of good agonists can have
identical triggering rates. Experimentally it is known that
antagonists can deliver negative or inactivation signals (37),
thus indicating that the TCR is capable of encoding agonist
quality. This may involve signaling from partially activated
complexes, which would have a higher representation under
shorter lifetime pMHC-TCR complexes, i.e., weak agonists.
These negative signals appear to enhance negative feedback
paths, but have different effects on different functions; spec-
iﬁcally, proliferation was inhibited but not cytotoxicity (58),
suggesting negative feedback works on long timescales.
Agonist quality koff and agonist density Mtotal may therefore
be separated during signal integration while thresholds
register only minimal stimulation requirements. Thus, mul-
tilayered signaling involving threshold signals and signal
integration provide a ﬂexible basis on which to deliver T-cell
function, ﬁrstly to ﬁlter out background levels of self-peptide
signaling, and secondly to allow optimal T cells to be selected
in an immune response based on agonist detection efﬁciency.
Experimentally there are key signatures for threshold
regulation and signal integration. Thresholds only have a
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discrete (ON/OFF) output, or two distinct states, while signal
integration can deliver relative or partial degrees of activa-
tion. Thus, for cell polarization and cytotoxicity, which are
discrete events, thresholds seem very likely. Of interest, how-
ever, is whether the threshold is on the triggering rate (l),
triggered TCR density (T*), or another downstream inte-
grated variable. Integrated signals have a quantitative output
that increases with antigen exposure, exposure incorporating
the two aspects of duration length and stimulus strength, both
of which should be tested since a threshold mechanism
may underpin the signal integration. Speciﬁcally integrated
outputs a ¼ R TðtÞdt and b ¼ time when T* . u both show
a correlation with stimulus duration; however, only a has a
correlation with stimulus strength (provided T* remains
above threshold u). Thus, although cytokine production in-
creases with the duration of antigen exposure (8), it is unclear
if cytokine output is also proportional to levels of T*, and
over what range, i.e., whether integration is through a
quantitative dependence such as a or b. This would require
different stimulus levels to be analyzed. The complication is
that at a population level, variation of thresholds between
cells or signal ﬂuctuations can give output b, or threshold
switching more generally, the appearance of a continuous
dependence on stimulus strength (or T*) through a change in
the number of cells responding at any one time. This can be
addressed through enrichment of subpopulations to remove
cell heterogeneity, e.g., sorting on TCR density, or through
single-cell experiments. Analysis of the dynamics of molec-
ular circuits and monitoring circuit variables is becoming in-
creasingly possible with noninvasive ﬂuorescent techniques
and can potentially distinguish these regulatory mechanisms
through a correlation analysis, comparing output (activation)
with different variables and their histories (integrations).
Experimentally different histories, before activation, would
need to be established—such as using antigen exposure inter-
vals with different levels of antigen. For example, single-cell
monitoring of NFkB nucleus levels would indicate if NFkB
nucleus levels are a better correlate of cytokine output than
antigen exposure, or their integrated analogs. Thus, through
a manipulation of antigen exposure proﬁles (strength and
duration) and observation of the activation and relaxation
kinetics of signal mediators, the particular dependencies of
a cell response can be ascertained, and thereby identify
where in a regulatory circuit thresholds are set and the mech-
anism underlying that threshold (e.g., negative feedback).
Ultimately, all threshold and signal integration strategies
must have a molecular circuit framework.
PARAMETERS
The model has ﬁve parameters. The surface density of TCR
is taken to be 30,000 (14), i.e., a surface density 100 mm2,
assuming a cell surface of 300 mm2. The downregulation rate
m(¼ md) is taken as 0.003 s1, which is the order of
magnitude estimated across a variety of studies (46,59). For
instance, after 7–15 min, 50% of the TCR are downregulated
at 20 mM peptide (estimated to be 9000 pMHC) (14). At this
density, within 1 min the majority of the receptors are
activated, thus the downregulation curve follows exp(rt).
This gives r ; 0.001 s1, and each activated receptor stays
around for 5–10 min. The loss rate of TCRs from the surface
is taken as m0 ¼ 0.01 min1 ¼ 0.00017 s1, estimated from
the secretion inhibition studies, 30% of the surface TCR is
lost in 15 min under primaquine treatment (45).
For the TCR/pMHC kinetics, we take a two-dimensional
afﬁnity of 20 molecules per mm2 for an optimal agonist (as
measured for CD2-CD48 interaction, which has similar
three-dimensional afﬁnities to the TCR/pMHC interaction)
(60). An optimal agonist has an off-rate (koff)optimal¼ 0.1 s1
(48).
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